Agenus Inc (NQ: AGEN )

3.560 USD UNCHANGED

Streaming Delayed Price Updated: 5:37 PM EST, Jan 20, 2021 Add to My Watchlist

Price and Volume

Volume	0
Open	3.560
Bid (Size)	3.550 (3)
Ask (Size)	3.610 (3)
Prev. Close	3.560
Today's Range	3.560 - 3.560
52wk Range	1.820 - 5.630
Shares Outstanding	103,999,081
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Agenus to Participate in B. Riley Securities' Oncology Investor Conference

January 19, 2021

Completion of Balstilimab BLA Filing Extended To 1H2021

December 03, 2020

Agenus to fulfill FDA feedback for six-month follow-up on late responders

Performance

YTD	+10.22%	+10.22%
1 Month	+2.89%	+2.89%
3 Month	-11.88%	-11.88%
6 Month	+0.85%	+0.85%
1 Year	-8.72%	-8.72%

More News

Agenus Launches Phase 2 Trial Expansion in Colon Cancer for AGEN1181 in Combination with Balstilimab

December 01, 2020

Agenus to Participate in Evercore ISI 3rd Annual HealthCONx Conference

November 25, 2020

3 Penny Stocks To Buy According To Analysts; 107%-195% Price Targets

December 01, 2020

Agenus to Participate in Fireside Chat at the Jefferies 2020 Virtual London Healthcare Conference

November 16, 2020

Agenus and Dr. Steven O’Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data

November 13, 2020

Agenus and Dr. Steven O’Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley

November 12, 2020

XOMA Earns First Milestone Payment from 2018 Royalty Purchase Agreement

November 11, 2020

An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2

November 10, 2020

VBI Vaccines Announces Positive Interim Phase 2a Data from VBI-1901 in Recurrent GBM

November 19, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.